This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Frederic Knoflach: Innovator in Neurological Treatments
Introduction
Frederic Knoflach is a notable inventor based in Arlesheim, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological disorders. His innovative work focuses on enhancing the understanding and treatment of conditions such as Alzheimer's disease and dementia.
Latest Patents
Frederic Knoflach holds a patent for "Oxazoles as mGluR1 enhancers." This invention relates to carboxamide derivatives, detailing a process for their preparation, pharmaceutical compositions that include them, and their application as mGluR1 enhancers. This advancement is particularly relevant for the treatment and prevention of neurological disorders and diseases.
Career Highlights
Knoflach is associated with Hoffmann-La Roche Inc., a leading global healthcare company. His work at this esteemed organization has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Frederic Knoflach has collaborated with notable colleagues, including Eric Vieira and Juergen Wichmann. These partnerships have fostered an environment of innovation and have been instrumental in advancing their shared goals in neurological research.
Conclusion
Frederic Knoflach's contributions to the field of pharmaceuticals, particularly through his patent on mGluR1 enhancers, highlight his commitment to improving treatments for neurological disorders. His work continues to inspire advancements in medical science.